Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | 12444684 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 75509.22 | nM | 22703163 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 89125.09 | nM | DrugMatrix in vitro pharmacology data | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 48752.85 | nM | 21452899 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 100000 | nM | 25924111 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 100000 | nM | 1360492 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 65614.53 | nM | 25066952 | |
NPT1176 | Organism | Mycobacterium fortuitum | Mycobacterium fortuitum | MIC | = | 2 | ug/ml | 23398362 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 100000 | nM | 26083682 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 100000 | nM | 21334794 | |
NPT348 | Organism | Myzus persicae | Myzus persicae | Inhibition | = | 20 | % | 23999046 |
NPT348 | Organism | Myzus persicae | Myzus persicae | Inhibition | = | 26 | % | 23999046 |
NPT348 | Organism | Myzus persicae | Myzus persicae | Inhibition | = | 63 | % | 23999046 |
NPT348 | Organism | Myzus persicae | Myzus persicae | Inhibition | = | 71 | % | 23999046 |
NPT348 | Organism | Myzus persicae | Myzus persicae | Inhibition | = | 62 | % | 23999046 |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 100000 | nM | 18771320 | |
NPT6293 | Organism | Mycobacterium sp. | Mycobacterium sp. | MIC | = | 2 | ug/ml | 20825224 |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 100000 | nM | Open TG-GATES in vivo data: Hematology | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 80537.84 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 100000 | nM | 14741273 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 100000 | nM | 23368884 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | 24119555 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 100000 | nM | 10346965 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | 19813743 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 100000 | nM | 10.6019/CHEMBL1201861 | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 100000 | nM | 12398540 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 100000 | nM | 18183025 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | 25237727 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 57942.87 | nM | 25237727 | |
NPT602 | Organism | Mycobacterium smegmatis | Mycobacterium smegmatis | MIC | = | 0.5 | ug/ml | 23675610 |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | 20145081 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | 17242147 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | 19128055 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | 19128055 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 91622.05 | nM | 18077363 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | 15165148 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 55847.02 | nM | 1336040 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 100000 | nM | 20541427 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | 17938185 | |
NPT2 | Others | Unspecified | IC50 | = | 98 | nM | 19223615 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 69023.98 | nM | 19506065 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 99083.19 | nM | 16038534 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 100000 | nM | 10869208 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 47097.73 | nM | 17358082 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 100000 | nM | 10.1007/s00044-011-9788-9 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 100000 | nM | 21550801 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 100000 | nM | 25453801 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 100000 | nM | 10869203 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | 9784093 | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 100000 | nM | 15104488 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 63679.55 | nM | 20594858 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | 20643897 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 100000 | nM | 20674349 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | 25420236 | |
NPT5372 | Individual Protein | Squalene-hopene cyclase | Alicyclobacillus acidocaldarius subsp. acidocaldarius (strain ATCC27009 / DSM 446 / 104-1A) (Bacillus acidocaldarius) | IC50 | = | 90000 | nM | PubChem BioAssay data set |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 83560.3 | nM | 21049906 | |
NPT1177 | Organism | Mycobacterium phlei | Mycobacterium phlei | MIC | = | 2 | ug/ml | 19581465 |
NPT5246 | Organism | Mycobacterium aurum | Mycobacterium aurum | MIC | = | 2 | ug/ml | 19581465 |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 99770.01 | nM | 19487444 | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 100000 | nM | 18625769 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 100000 | nM | 22931300 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | 20346682 | |
NPT348 | Organism | Myzus persicae | Myzus persicae | Inhibition | = | 28 | % | 19708637 |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 99083.19 | nM | 14640569 | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 100000 | nM | 22209731 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC470092 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9035 | High Similarity | NPC279916 |
0.8898 | High Similarity | NPC54243 |
0.8814 | High Similarity | NPC32298 |
0.8739 | High Similarity | NPC201284 |
0.8718 | High Similarity | NPC188907 |
0.8707 | High Similarity | NPC53953 |
0.8689 | High Similarity | NPC93730 |
0.8655 | High Similarity | NPC171023 |
0.8618 | High Similarity | NPC193805 |
0.8618 | High Similarity | NPC56332 |
0.8583 | High Similarity | NPC35744 |
0.8571 | High Similarity | NPC187907 |
0.8571 | High Similarity | NPC217423 |
0.8548 | High Similarity | NPC2771 |
0.8537 | High Similarity | NPC472888 |
0.848 | Intermediate Similarity | NPC474264 |
0.8475 | Intermediate Similarity | NPC114144 |
0.8455 | Intermediate Similarity | NPC311219 |
0.845 | Intermediate Similarity | NPC477536 |
0.8438 | Intermediate Similarity | NPC324488 |
0.8435 | Intermediate Similarity | NPC224584 |
0.8425 | Intermediate Similarity | NPC473019 |
0.8417 | Intermediate Similarity | NPC469954 |
0.8413 | Intermediate Similarity | NPC22783 |
0.8413 | Intermediate Similarity | NPC298884 |
0.84 | Intermediate Similarity | NPC4164 |
0.8387 | Intermediate Similarity | NPC182646 |
0.8376 | Intermediate Similarity | NPC23332 |
0.8374 | Intermediate Similarity | NPC314329 |
0.8361 | Intermediate Similarity | NPC230951 |
0.8361 | Intermediate Similarity | NPC474874 |
0.8359 | Intermediate Similarity | NPC7569 |
0.8346 | Intermediate Similarity | NPC125887 |
0.8333 | Intermediate Similarity | NPC477534 |
0.8333 | Intermediate Similarity | NPC128825 |
0.8333 | Intermediate Similarity | NPC19290 |
0.8321 | Intermediate Similarity | NPC298900 |
0.832 | Intermediate Similarity | NPC470162 |
0.832 | Intermediate Similarity | NPC470163 |
0.8291 | Intermediate Similarity | NPC183648 |
0.8281 | Intermediate Similarity | NPC211120 |
0.8279 | Intermediate Similarity | NPC328459 |
0.8279 | Intermediate Similarity | NPC90522 |
0.8268 | Intermediate Similarity | NPC470841 |
0.8268 | Intermediate Similarity | NPC41721 |
0.8268 | Intermediate Similarity | NPC293387 |
0.8264 | Intermediate Similarity | NPC45104 |
0.8254 | Intermediate Similarity | NPC65041 |
0.8254 | Intermediate Similarity | NPC224657 |
0.8244 | Intermediate Similarity | NPC188646 |
0.8244 | Intermediate Similarity | NPC263670 |
0.8244 | Intermediate Similarity | NPC312318 |
0.8244 | Intermediate Similarity | NPC472365 |
0.8244 | Intermediate Similarity | NPC242294 |
0.8244 | Intermediate Similarity | NPC192304 |
0.8244 | Intermediate Similarity | NPC56031 |
0.8244 | Intermediate Similarity | NPC139813 |
0.8244 | Intermediate Similarity | NPC337373 |
0.8244 | Intermediate Similarity | NPC175098 |
0.824 | Intermediate Similarity | NPC473942 |
0.8231 | Intermediate Similarity | NPC186097 |
0.8231 | Intermediate Similarity | NPC475009 |
0.8231 | Intermediate Similarity | NPC64359 |
0.8231 | Intermediate Similarity | NPC475008 |
0.8231 | Intermediate Similarity | NPC118253 |
0.8231 | Intermediate Similarity | NPC308037 |
0.8231 | Intermediate Similarity | NPC474340 |
0.8231 | Intermediate Similarity | NPC262359 |
0.8217 | Intermediate Similarity | NPC39753 |
0.8217 | Intermediate Similarity | NPC115998 |
0.8211 | Intermediate Similarity | NPC72977 |
0.8203 | Intermediate Similarity | NPC80694 |
0.8203 | Intermediate Similarity | NPC186098 |
0.8203 | Intermediate Similarity | NPC475017 |
0.8197 | Intermediate Similarity | NPC94637 |
0.8189 | Intermediate Similarity | NPC237868 |
0.8182 | Intermediate Similarity | NPC281513 |
0.8182 | Intermediate Similarity | NPC286336 |
0.8182 | Intermediate Similarity | NPC22222 |
0.8175 | Intermediate Similarity | NPC313039 |
0.8175 | Intermediate Similarity | NPC473976 |
0.8175 | Intermediate Similarity | NPC109812 |
0.8175 | Intermediate Similarity | NPC131043 |
0.8175 | Intermediate Similarity | NPC6888 |
0.8175 | Intermediate Similarity | NPC91475 |
0.8175 | Intermediate Similarity | NPC4012 |
0.8175 | Intermediate Similarity | NPC198459 |
0.8175 | Intermediate Similarity | NPC265910 |
0.8168 | Intermediate Similarity | NPC212631 |
0.8168 | Intermediate Similarity | NPC205468 |
0.8168 | Intermediate Similarity | NPC10971 |
0.8168 | Intermediate Similarity | NPC257756 |
0.8168 | Intermediate Similarity | NPC87231 |
0.8168 | Intermediate Similarity | NPC129132 |
0.8154 | Intermediate Similarity | NPC301717 |
0.8154 | Intermediate Similarity | NPC137264 |
0.8154 | Intermediate Similarity | NPC205360 |
0.8148 | Intermediate Similarity | NPC477537 |
0.814 | Intermediate Similarity | NPC197425 |
0.814 | Intermediate Similarity | NPC60558 |
0.814 | Intermediate Similarity | NPC238309 |
0.8125 | Intermediate Similarity | NPC71525 |
0.8125 | Intermediate Similarity | NPC264428 |
0.8125 | Intermediate Similarity | NPC45537 |
0.812 | Intermediate Similarity | NPC131039 |
0.8115 | Intermediate Similarity | NPC240664 |
0.8115 | Intermediate Similarity | NPC269414 |
0.8106 | Intermediate Similarity | NPC82225 |
0.8106 | Intermediate Similarity | NPC18877 |
0.8106 | Intermediate Similarity | NPC294593 |
0.8106 | Intermediate Similarity | NPC204960 |
0.8106 | Intermediate Similarity | NPC223354 |
0.8106 | Intermediate Similarity | NPC159623 |
0.8106 | Intermediate Similarity | NPC20560 |
0.8106 | Intermediate Similarity | NPC144051 |
0.8106 | Intermediate Similarity | NPC28753 |
0.8092 | Intermediate Similarity | NPC313618 |
0.8092 | Intermediate Similarity | NPC470160 |
0.8092 | Intermediate Similarity | NPC284424 |
0.8087 | Intermediate Similarity | NPC38209 |
0.8077 | Intermediate Similarity | NPC278787 |
0.8077 | Intermediate Similarity | NPC327457 |
0.8077 | Intermediate Similarity | NPC86774 |
0.8077 | Intermediate Similarity | NPC185497 |
0.8074 | Intermediate Similarity | NPC473988 |
0.8065 | Intermediate Similarity | NPC233282 |
0.8062 | Intermediate Similarity | NPC196034 |
0.8062 | Intermediate Similarity | NPC473907 |
0.806 | Intermediate Similarity | NPC41461 |
0.806 | Intermediate Similarity | NPC472367 |
0.806 | Intermediate Similarity | NPC274109 |
0.806 | Intermediate Similarity | NPC66349 |
0.806 | Intermediate Similarity | NPC476333 |
0.806 | Intermediate Similarity | NPC150399 |
0.806 | Intermediate Similarity | NPC473391 |
0.806 | Intermediate Similarity | NPC25287 |
0.806 | Intermediate Similarity | NPC168105 |
0.806 | Intermediate Similarity | NPC472364 |
0.806 | Intermediate Similarity | NPC240593 |
0.806 | Intermediate Similarity | NPC186838 |
0.806 | Intermediate Similarity | NPC13408 |
0.806 | Intermediate Similarity | NPC1486 |
0.806 | Intermediate Similarity | NPC477244 |
0.806 | Intermediate Similarity | NPC249606 |
0.806 | Intermediate Similarity | NPC98115 |
0.806 | Intermediate Similarity | NPC213603 |
0.806 | Intermediate Similarity | NPC12165 |
0.806 | Intermediate Similarity | NPC477243 |
0.806 | Intermediate Similarity | NPC477242 |
0.8051 | Intermediate Similarity | NPC234639 |
0.8034 | Intermediate Similarity | NPC141523 |
0.8033 | Intermediate Similarity | NPC33717 |
0.8033 | Intermediate Similarity | NPC477453 |
0.8033 | Intermediate Similarity | NPC470860 |
0.8031 | Intermediate Similarity | NPC89630 |
0.803 | Intermediate Similarity | NPC101294 |
0.803 | Intermediate Similarity | NPC473655 |
0.803 | Intermediate Similarity | NPC287533 |
0.803 | Intermediate Similarity | NPC229646 |
0.803 | Intermediate Similarity | NPC182428 |
0.8017 | Intermediate Similarity | NPC227255 |
0.8016 | Intermediate Similarity | NPC46634 |
0.8015 | Intermediate Similarity | NPC477535 |
0.8015 | Intermediate Similarity | NPC141549 |
0.8015 | Intermediate Similarity | NPC5515 |
0.8015 | Intermediate Similarity | NPC270369 |
0.8 | Intermediate Similarity | NPC253616 |
0.8 | Intermediate Similarity | NPC153979 |
0.8 | Intermediate Similarity | NPC188879 |
0.8 | Intermediate Similarity | NPC57552 |
0.8 | Intermediate Similarity | NPC303644 |
0.8 | Intermediate Similarity | NPC7013 |
0.8 | Intermediate Similarity | NPC298224 |
0.8 | Intermediate Similarity | NPC250266 |
0.8 | Intermediate Similarity | NPC228661 |
0.8 | Intermediate Similarity | NPC266597 |
0.8 | Intermediate Similarity | NPC209560 |
0.8 | Intermediate Similarity | NPC472419 |
0.8 | Intermediate Similarity | NPC181124 |
0.8 | Intermediate Similarity | NPC116632 |
0.8 | Intermediate Similarity | NPC473894 |
0.8 | Intermediate Similarity | NPC294409 |
0.8 | Intermediate Similarity | NPC162680 |
0.8 | Intermediate Similarity | NPC317119 |
0.8 | Intermediate Similarity | NPC332594 |
0.7985 | Intermediate Similarity | NPC151113 |
0.7985 | Intermediate Similarity | NPC156092 |
0.7985 | Intermediate Similarity | NPC13575 |
0.7985 | Intermediate Similarity | NPC472881 |
0.7984 | Intermediate Similarity | NPC121104 |
0.7984 | Intermediate Similarity | NPC305518 |
0.7984 | Intermediate Similarity | NPC264976 |
0.7984 | Intermediate Similarity | NPC43435 |
0.7984 | Intermediate Similarity | NPC37512 |
0.7984 | Intermediate Similarity | NPC475496 |
0.7984 | Intermediate Similarity | NPC61779 |
0.7984 | Intermediate Similarity | NPC49852 |
0.7984 | Intermediate Similarity | NPC128428 |
0.7984 | Intermediate Similarity | NPC181715 |
0.797 | Intermediate Similarity | NPC57601 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC470092 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9412 | High Similarity | NPD2798 | Approved |
0.8455 | Intermediate Similarity | NPD9717 | Approved |
0.8374 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.8359 | Intermediate Similarity | NPD2313 | Discontinued |
0.8346 | Intermediate Similarity | NPD6832 | Phase 2 |
0.8333 | Intermediate Similarity | NPD9493 | Approved |
0.8258 | Intermediate Similarity | NPD2799 | Discontinued |
0.8254 | Intermediate Similarity | NPD1203 | Approved |
0.8222 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8092 | Intermediate Similarity | NPD1240 | Approved |
0.8083 | Intermediate Similarity | NPD1241 | Discontinued |
0.806 | Intermediate Similarity | NPD2935 | Discontinued |
0.803 | Intermediate Similarity | NPD1933 | Approved |
0.8016 | Intermediate Similarity | NPD3972 | Approved |
0.797 | Intermediate Similarity | NPD1607 | Approved |
0.7969 | Intermediate Similarity | NPD2797 | Approved |
0.7926 | Intermediate Similarity | NPD2796 | Approved |
0.7907 | Intermediate Similarity | NPD1019 | Discontinued |
0.7881 | Intermediate Similarity | NPD9264 | Approved |
0.7881 | Intermediate Similarity | NPD9263 | Approved |
0.7881 | Intermediate Similarity | NPD9267 | Approved |
0.7868 | Intermediate Similarity | NPD2346 | Discontinued |
0.7868 | Intermediate Similarity | NPD2344 | Approved |
0.7852 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7845 | Intermediate Similarity | NPD9261 | Approved |
0.7815 | Intermediate Similarity | NPD74 | Approved |
0.7815 | Intermediate Similarity | NPD9266 | Approved |
0.7803 | Intermediate Similarity | NPD411 | Approved |
0.7803 | Intermediate Similarity | NPD3268 | Approved |
0.7786 | Intermediate Similarity | NPD6799 | Approved |
0.7761 | Intermediate Similarity | NPD447 | Suspended |
0.7761 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7752 | Intermediate Similarity | NPD1876 | Approved |
0.7742 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7721 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7712 | Intermediate Similarity | NPD9697 | Approved |
0.7692 | Intermediate Similarity | NPD3267 | Approved |
0.7692 | Intermediate Similarity | NPD3266 | Approved |
0.7687 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7643 | Intermediate Similarity | NPD2309 | Approved |
0.7626 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD5403 | Approved |
0.7606 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD5401 | Approved |
0.7606 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD4662 | Approved |
0.7606 | Intermediate Similarity | NPD4661 | Approved |
0.7554 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7554 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7536 | Intermediate Similarity | NPD1551 | Phase 2 |
0.75 | Intermediate Similarity | NPD3134 | Approved |
0.75 | Intermediate Similarity | NPD1243 | Approved |
0.7482 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7482 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7482 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.748 | Intermediate Similarity | NPD9545 | Approved |
0.7466 | Intermediate Similarity | NPD6599 | Discontinued |
0.7464 | Intermediate Similarity | NPD3748 | Approved |
0.7447 | Intermediate Similarity | NPD3750 | Approved |
0.7447 | Intermediate Similarity | NPD7003 | Approved |
0.744 | Intermediate Similarity | NPD9281 | Approved |
0.7426 | Intermediate Similarity | NPD3140 | Approved |
0.7426 | Intermediate Similarity | NPD3142 | Approved |
0.7415 | Intermediate Similarity | NPD7411 | Suspended |
0.74 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD7458 | Discontinued |
0.7397 | Intermediate Similarity | NPD3226 | Approved |
0.7394 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7385 | Intermediate Similarity | NPD1201 | Approved |
0.7383 | Intermediate Similarity | NPD7318 | Phase 3 |
0.7365 | Intermediate Similarity | NPD6844 | Discontinued |
0.7365 | Intermediate Similarity | NPD6801 | Discontinued |
0.7364 | Intermediate Similarity | NPD4626 | Approved |
0.7351 | Intermediate Similarity | NPD3252 | Approved |
0.7348 | Intermediate Similarity | NPD3225 | Approved |
0.7347 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7344 | Intermediate Similarity | NPD1894 | Discontinued |
0.7339 | Intermediate Similarity | NPD1609 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD1608 | Approved |
0.7315 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7315 | Intermediate Similarity | NPD7819 | Suspended |
0.7308 | Intermediate Similarity | NPD3496 | Discontinued |
0.7308 | Intermediate Similarity | NPD3847 | Discontinued |
0.7295 | Intermediate Similarity | NPD1358 | Approved |
0.7293 | Intermediate Similarity | NPD1470 | Approved |
0.7293 | Intermediate Similarity | NPD1164 | Approved |
0.7292 | Intermediate Similarity | NPD1511 | Approved |
0.7287 | Intermediate Similarity | NPD1651 | Approved |
0.7287 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD6798 | Discontinued |
0.7267 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7267 | Intermediate Similarity | NPD5402 | Approved |
0.7266 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7254 | Intermediate Similarity | NPD2654 | Approved |
0.7252 | Intermediate Similarity | NPD422 | Phase 1 |
0.7248 | Intermediate Similarity | NPD7317 | Phase 3 |
0.7244 | Intermediate Similarity | NPD709 | Approved |
0.7234 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7231 | Intermediate Similarity | NPD1778 | Approved |
0.7231 | Intermediate Similarity | NPD17 | Approved |
0.723 | Intermediate Similarity | NPD6585 | Discontinued |
0.7222 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7218 | Intermediate Similarity | NPD1283 | Approved |
0.7214 | Intermediate Similarity | NPD7033 | Discontinued |
0.7203 | Intermediate Similarity | NPD4628 | Phase 3 |
0.72 | Intermediate Similarity | NPD2801 | Approved |
0.7197 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7194 | Intermediate Similarity | NPD6651 | Approved |
0.7192 | Intermediate Similarity | NPD1512 | Approved |
0.7192 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7185 | Intermediate Similarity | NPD9494 | Approved |
0.7181 | Intermediate Similarity | NPD5890 | Approved |
0.7181 | Intermediate Similarity | NPD5889 | Approved |
0.7171 | Intermediate Similarity | NPD7075 | Discontinued |
0.7154 | Intermediate Similarity | NPD5691 | Approved |
0.7154 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD2354 | Approved |
0.7143 | Intermediate Similarity | NPD920 | Approved |
0.7143 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD5535 | Approved |
0.7143 | Intermediate Similarity | NPD1238 | Approved |
0.7143 | Intermediate Similarity | NPD1138 | Approved |
0.7123 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7122 | Intermediate Similarity | NPD6355 | Discontinued |
0.7121 | Intermediate Similarity | NPD1535 | Discovery |
0.7121 | Intermediate Similarity | NPD1281 | Approved |
0.712 | Intermediate Similarity | NPD2181 | Clinical (unspecified phase) |
0.7113 | Intermediate Similarity | NPD2353 | Approved |
0.7113 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7111 | Intermediate Similarity | NPD5647 | Approved |
0.7109 | Intermediate Similarity | NPD6671 | Approved |
0.7109 | Intermediate Similarity | NPD6387 | Discontinued |
0.7105 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7105 | Intermediate Similarity | NPD3882 | Suspended |
0.7097 | Intermediate Similarity | NPD2684 | Approved |
0.7097 | Intermediate Similarity | NPD2182 | Approved |
0.7086 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD2366 | Approved |
0.7063 | Intermediate Similarity | NPD1137 | Approved |
0.7063 | Intermediate Similarity | NPD1139 | Approved |
0.7049 | Intermediate Similarity | NPD164 | Approved |
0.7049 | Intermediate Similarity | NPD5909 | Discontinued |
0.7047 | Intermediate Similarity | NPD2649 | Approved |
0.7047 | Intermediate Similarity | NPD2651 | Approved |
0.7042 | Intermediate Similarity | NPD4477 | Approved |
0.7042 | Intermediate Similarity | NPD4476 | Approved |
0.7039 | Intermediate Similarity | NPD2296 | Approved |
0.7039 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7034 | Intermediate Similarity | NPD3887 | Approved |
0.7031 | Intermediate Similarity | NPD690 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7029 | Intermediate Similarity | NPD3764 | Approved |
0.7027 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD3818 | Discontinued |
0.7023 | Intermediate Similarity | NPD5585 | Approved |
0.702 | Intermediate Similarity | NPD1934 | Approved |
0.702 | Intermediate Similarity | NPD6279 | Approved |
0.702 | Intermediate Similarity | NPD6280 | Approved |
0.7016 | Intermediate Similarity | NPD290 | Approved |
0.7014 | Intermediate Similarity | NPD2800 | Approved |
0.7007 | Intermediate Similarity | NPD2614 | Approved |
0.7 | Intermediate Similarity | NPD4618 | Approved |
0.7 | Intermediate Similarity | NPD4622 | Approved |
0.6986 | Remote Similarity | NPD7440 | Discontinued |
0.6981 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6981 | Remote Similarity | NPD7054 | Approved |
0.6978 | Remote Similarity | NPD6233 | Phase 2 |
0.6978 | Remote Similarity | NPD4062 | Phase 3 |
0.6978 | Remote Similarity | NPD520 | Approved |
0.6966 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.696 | Remote Similarity | NPD6831 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD6273 | Approved |
0.6948 | Remote Similarity | NPD3749 | Approved |
0.6939 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6937 | Remote Similarity | NPD7472 | Approved |
0.6933 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6929 | Remote Similarity | NPD943 | Approved |
0.6929 | Remote Similarity | NPD2203 | Discontinued |
0.6911 | Remote Similarity | NPD1237 | Approved |
0.6905 | Remote Similarity | NPD5451 | Approved |
0.6901 | Remote Similarity | NPD5688 | Approved |
0.6901 | Remote Similarity | NPD5689 | Approved |
0.6899 | Remote Similarity | NPD7852 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD9258 | Approved |
0.6897 | Remote Similarity | NPD9256 | Approved |
0.6894 | Remote Similarity | NPD6797 | Phase 2 |
0.6892 | Remote Similarity | NPD2532 | Approved |
0.6892 | Remote Similarity | NPD2534 | Approved |
0.6892 | Remote Similarity | NPD2533 | Approved |
0.6879 | Remote Similarity | NPD1184 | Approved |
0.6875 | Remote Similarity | NPD7843 | Approved |
0.6871 | Remote Similarity | NPD160 | Clinical (unspecified phase) |
0.6864 | Remote Similarity | NPD1202 | Approved |
0.686 | Remote Similarity | NPD2066 | Phase 3 |
0.6857 | Remote Similarity | NPD8032 | Phase 2 |
0.6852 | Remote Similarity | NPD7251 | Discontinued |
0.6852 | Remote Similarity | NPD6559 | Discontinued |
0.6842 | Remote Similarity | NPD9259 | Approved |
0.6842 | Remote Similarity | NPD9257 | Approved |
PubChem CID   | |
ChEMBL   | CHEMBL174839 |
ZINC   |
Molecular Weight:   | 366.22 |
ALogP:   | 4.0891 |
MLogP:   | 3.77 |
XLogP:   | 7.671 |
# Rotatable Bonds:   | 13 |
Polar Surface Area:   | 46.53 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 27 |